Korean J Clin Oncol.  2020 Dec;16(2):145-147. 10.14216/kjco.20023.

Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node

Affiliations
  • 1Department of Surgery, Pusan National University Hospital, Busan, Korea
  • 2Department of Surgery, Pusan National University Yangsan Hospital,Yangsan, Korea
  • 3Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea

Abstract

Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.

Keyword

Papillary thyroid carcinoma; Thyrotropin; Active surveillance; Locoregional neoplasm recurrence; Case report
Full Text Links
  • KJCO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr